ARTICLE | Clinical News
ZP-Triptan: Phase I data
November 9, 2015 8:00 AM UTC
A crossover Phase I trial in 20 healthy volunteers showed that single and double doses of 0.48 and 1.9 mg ZP-Triptan and a single dose of 3.8 mg ZP-Triptan were well tolerated. Additionally, Zosano sa...